Why Is BioNTech Stock Falling Tuesday?

On Tuesday, BioNTech SE (NASDAQ:BNTX) reported initial findings from the AHEAD-MERIT Phase 2/3 clinical trial assessing BNT113, an investigational mRNA cancer immunotherapy. Following the announcement, the stock fell more than 5%. The study evaluates BNT113 paired...

Crude Oil Edges Higher; Citigroup Earnings Top Views

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded down 0.25% to 51,718.96 while the NASDAQ fell 0.19% to 27,194.25. The S&P 500 also fell, dropping, 0.14% to 7,796.43. Leading and Lagging...

Oracle Stock Moves Higher: What’s Happening?

Oracle Corp (NYSE:ORCL) shares are climbing Tuesday. The company revealed a power plan for its Project Jupiter data center and joined Marvell and Microsoft to set a new server security standard. Here’s what you should know. Oracle stock is gaining positive traction....